| Line item | 2025-12-31 FY | 2024-12-31 FY | 2024-10-02 FY | 2024-02-22 FY | 2023-12-31 FY | 2023-10-11 FY | 2022-12-31 FY |
|---|---|---|---|---|---|---|---|
| Revenue | – | – | $50.00M | $50.00M | – | – | – |
| Cost of Revenue | – | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – | – |
| Operating Expenses | $160.42M | $4.69M | – | – | – | – | – |
| R&D | $2.55M | $1.71M | – | – | – | – | – |
| SG&A | $157.87M | $2.98M | – | – | – | – | – |
| Operating Income | -$160.42M | -$1.65M | – | – | -$3.17M | – | – |
| Interest Expense | – | $96.24K | – | – | $36.91K | $100.00K | – |
| Tax Expense | $0.00 | $0.00 | – | – | – | – | – |
| Net Income | -$160.42M | -$167.31K | – | – | $632.54K | – | -$419.39K |
| EPS (basic) | -0.7800 | -0.0200 | – | – | – | – | – |
| EPS (diluted) | -0.7800 | -0.0200 | – | – | – | – | – |
| Shares (diluted) | $204.78M | $200.00M | – | – | – | – | – |